The biology and pathobiology of Schwann cells

Current Opinion in Neurology

Volumn 10, Issue 5, 1997, Pages 386-397

  Scherer, Steven S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL MODEL; CELL INTERACTION; DEMYELINATING NEUROPATHY; DENERVATION; EXTRACELLULAR MATRIX; GENE; GENE MUTATION; HUMAN; MOUSE; MYELIN SHEATH; NERVE CELL DIFFERENTIATION; NERVE FIBER; NERVE INJURY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW; SCHWANN CELL;

EID: 0030765350     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199710000-00006     Document Type: Review

References (107)

1. Shan NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ: Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 1994, 77:349-360.
2. •].
3. •] provide comprehensive reviews on the cellular and molecular biology of neuregulins and their receptors.
4. Levi ADO, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX: The influence of heregulins on human Schwann cell proliferation. J Neurosci 1995, 15:1329-1340.
5. Grinspan JB, Marchionni M, Reeves M, Coulaloglou M, Scherer SS: Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 1996, 16:6107-6118. Premyelinating Schwann cells express erbB2 and erbB3, and are rescued from axotomy-induced apoptosis by exogenous neuregulin.
6. Syroid DE, Maycox PR, Burrola PG, Liu N, Wen D, Lee K-F, Lemke G, Kilpatrick TJ: Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci U S A 1996, 93:9229-9234. Neuregulin prevents apoptosis of cultured Schwann cells, which express erbB2 and erbB3 mRNA.
7. Meyer D, Birchmeier C: Multiple essential functions of neuregulin in development. Nature 1995, 378:386-390.
8. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR: Neu differentiation factor acts as a neuron-glia signal and regulates the survival, proliferation and maturation of the rat Schwann cell precursor. Neuron 1995, 15:585-596.
9. Ciutat D, Caldero J, Oppenheim RW, Esquerda JE: Schwann cell apoptosis during normal development and after axonal degeneration induced by neurotoxins in the chick embryo. J Neurosci 1996, 16:3979-3990.
10. Trachenberg JT, Thompson WJ: Schwann cell apoptosis and its regulation at the developing neuromuscular junction. Nature 1996, 379:174-177. Terminal Schwann cells of neonatal neuromuscular junctions undergo massive apoptosis that can be completely prevented by exogenous neuregulins.
11. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, Charnay P: The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 1996, 122:2847-2857. Neuregulins are essential for the expression of Krox-20 by cultured Schwann cells.
12. Mirsky R, Jessen KR: Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 1996, 6:89-96.
13. Berger UV, Schwab ME: N-Acetylated alpha-linked acidic dipeptidase may be involved in axon-Schwann cell signalling. J Neurocytol 1996, 25:499-512.
14. Thomaidou D, Yfanti E, Patsavoudi E: Expression of the 4C5 antigen during development and after injury of the rat sciatic nerve. J Neurosci Res 1996, 46:24-33.
15. Wewetzer K, Grothe C, Christ B, Scilheimer B: Identification and characterization of differentiation-dependent Schwann cell surface antigens by novel monoclonal antibodies: introduction of a marker common to the non-myelin-forming phenotype. Glia 1997, 19:213-226.
16. Guenard V, Montag D, Schachner M, Martini R: Onion bulb cells in mice dificient for myelin genes share molecular properties with immature, differentiated non-myelinating, and denervated Schwann cells. Glia 1996, 18:27-38.
17. Quattrini A, Previtali S, Feltri ML, Canal N, Nemni R, Wrabetz L: β4 integrin and other Schwann cell markers in axonal neuropathy. Glia 1996, 17:294-306.
18. Scherer SS, Salzer JL: Axon-Schwann cell interactions in peripheral nerve regeneration. In Glial Cell Development. Edited by Jessen KR, Richardson WD. Oxford: Bios Scientific Publishers; 1996:165-196.
19. Zorick TS, Lemke G: Schwann cell differentiation. Curr Opin Cell Biol 1996, 8:870-876.
20. Poduslo JF, Walikonis RS, Domec M-C, Berg CT, Holtz-Heppelmann CJ: The second messenger, cyclic AMP, is not sufficient for myelin gene induction in the peripheral nervous system. J Neurochem 1995, 65:149-159.
21. Cheng L, Mudge AW: Cultured Schwann cells constitutively express the myelin protein PO. Neuron 1996, 16:309-319.
22. Scherer SS, Wang D-Y, Kuhn R, Lemke G, Wrabetz L, Kamholz J: Axons regulate Schwann cell expression of he POU transcription factor SCIP. J Neurosci 1994, 14:1930-1942.
23. 0 is constitutively expressed in the rat neural crest and embryonic nerves and Is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol Cell Neurosci 1997, 8:336-350.
24. Kioussi C, Gross MK, Gruss P: Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 1995, 15:553-562.
25. Stewart HJS: Expression of c-jun, jun B, jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur J Neurosci 1995, 7:1366-1375.
26. Shy M, Shi Y-J, Wrabetz L, Kamholz J, Scherer SS: Axon-Schwann cell interactions regulate the expression of c-jun in Schwann cells. J Neurosci Res 1996, 43:511-525.
27. Nikam SS, Tennekoon GI, Christy B, Yoshino JE, Rutkowski JL: The zinc finger transcription factor Zif268/Egr-1 is essential for Schwann cell expression of the p75 NGF receptor. Mol Cell Neurosci 1995, 6:337-348.
28. Vaudano E, Campbell G, Hunt SP: Change in the molecular phenotype of Schwann cells upon transplantation into the central nervous system: down-regulation of c-jun. Neuroscience 1996, 74:553-565.
29. Blanchard AD, Sinanan A, Parantier E, Zwart R, Broos L, Meijer D, Meier C, Jessen KR, Mirsky R: Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res 1996, 46:630-640.
30. ••].
31. ••] show that myelinating Schwann cells do not develop normally in SCIP/tst-1/Oct-6-null mice, transiently arresting at the promyelinating stage.
32. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercoon A, Ben Younes, Chennoufi A, Seitanidou T, Babinet C, Charnay P: Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
33. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G: The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 1996, 8:129-145.
34. 0 forms tetramers.
35. 0 interacts with negatively charge phospholipid bilayers. J Biol Chem 1995, 269:10764-10770.
36. 0 protein truncated in its cytoplasmic domain. J Cell Biol 1996, 134:1531-1541.
37. Fannon AM, Scherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL, Colman DR: Novel E-cadherin mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 1995, 129:189-202.
38. Scherer SS, Deschênes SM, Xu Y-T, Grinspan JB, Fischbeck KH, Paul DL: Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 1995, 15:8281-8294.
39. Suter U, Snipes GJ: Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 1995, 18:45-75.
40. Ionasescu VV, Ionasescu R, Searby C: Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve 1993, 16:1232-1238.
41. Vallat JM, Sindou P, Preux PM, Tabaraud F, Milor AM, Couratier P, Leguren E, Brice A: Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996, 39:813-817. Immunogold labeling demonstrates that the relative amount of PMP22 in myelin is dose-related: higher in patients with a duplicated PMP22 allele and lower in patients with a deleted PMP22 allele.
42. Gabreels-Festern AAWM, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJHM, Gabreels FJM: Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995, 90:645-649.
43. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F: A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marine-Tooth disease type 1A. Neurology 1997, 48:489-493.
44. Navon R, Seifried B, Galon NS, Sadeh M: A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe, de novo Charcot-Marie-Tooth disease. Hum Genet 1996, 97:685-687.
45. Chance PF, Alderson MK, Lepping KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD: DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993, 72:143-151.
46. Nicholson G, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, Mcleod JG, Bolhuis PA, Baas F: A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet 1994, 6:263-266.
47. Young P, Wiebusch H, Stogbauer F, Ringelstein B, Assmann G, Funke H: A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure plasies. Neurology 1997, 48:450-452.
48. Schenone A, Nobbio L, Mandich P, Bellone E, Abbruzzese M, Aymar F, Mancardi GL, Windebank AJ: Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997, 48:445-449.
49. Kiyosawa H, Chance PF: Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 1996, 5:745-753.
50. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR: A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nature Genet 1996, 12:288-287.
51. 0.
52. Ikegami T, Nicholson G, Ikeda H, Ishida A, Johnston H, Wise G, Ouvrier R, Hayasaka K: A novel homozygous mutation of the myelin P0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 1996, 222:107-110.
53. Gabreels-Festen AAWM, Hoogendijk JE, Meijerink FGI, Devisser M et al.: Two divergent types of nerve pathology in patients with different P0 mutation in Charcot-Marie-Tooth disease. Neurology 1996, 47:761-765.
54. Kirschner DA, Szumowski K, Gabreels-Festen AAWM, Hoogendijk JE, Bolhuis PA: Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to PO molecular defects. J NeuroSci Res 1996, 46:502-508.
55. Scherer SS, Bone LJ, Deschênes SM, Fischbeck K, Balice-Gordon R: The role of the gap junction protein connexin32 in the myelin sheath. in Cell Biology and Pathology of Myelin: Evolving Biological Concepts and Therapeutic Approaches. Edited by Devon RM, Doucette R, Juurink BHJ, Nazarali AJ, Schreyer DJ, Verge VMK. New York: Plenum Press; 197:83-102.
56. Bruzzone R, White TW, Scherer SS, Fischbeck KH, Paul DL: Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 1994, 13:1253-1260.
57. Rabadan-Diehl C, Dahl G, Werner R: A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett 1994, 351:90-94.
58. Omori Y, Mesnil M, Yamasaki H: Connexin 32 mutations associated with Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol Biol Cell 1996, 7:907-916.
59. Ionasescu V, Ionasescu R, Searby C: Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neurology. Am J Med Genet 1996, 63:486-491.
60. Harding AE: From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 1995, 118:809-818.
61. •].
62. •].
63. •] show that overexpression of PMP22 causes dominantly inherited demyelinating neuropathy in rats and mice.
64. Smit JJM, Bass F, Hoogendijk JE, Jansen GH, Vandervalk M-A, Schinkel AH, Berns AJM, Acton D, Nooter K, Burger H et al. Peripheral neuropathy in mice transgenic for a human MDR3 P-glycoprotein mini-gene. J Neurosci 1996, 16:6386-6393.
65. Adlkofer K, Martini H, Aguzzi A, Zielasek J, Toyka KV, Suter U: Hypermyelination and demyelinating peripheral neuropathy in pmp22-deficient mice. Nature Genet 1995, 11:274-280.
66. Adlkofer K, Frei R, Neuaberg DH-H, Zielasek J, Toyka KV, Suter U: Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating peripheral neuropathy. J Neurosci 1997, 17:4662-4671. Adult mice with one normal and one null PMP22 allele develop a demyelinating neuropathy that has many of the features of HNPP.
67. Ionasescu VV, Searby CC, Ionasescu R, Chatkupt S, Patel N, Koenigsberger R: Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 1997, 20:97-99.
68. Hoogendijk JE, Janssen EAM, Gabreels-Festen AAWM, Hensels GW, Joosten EMG, Gabreels FJM, Zorn I, Valentijn LJ, Baas F, Ongerboer de Visser BW, Bolhuis PA: Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type Ia). Neurology 1993, 43:1010-1015.
69. ••].
70. ••] show that although Tr and Tr mice both have missense mutations in PMP22, the mutation PMP22 protein is aberrantly processed in different ways in the different mutations, underscoring the likelihood that different missense mutations of the same gene may have different effects.
71. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
72. Martini R, Mohajeri MH, Kasper S, Giese KP, Schachner M: Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 1995, 15:4488-4495.
73. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M: Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves a characteristic of inherited human neuropathies. Nature Genet 1995, 11:281-285.
74. 0 gene mutations. Muscle Nerve 1996, 19:946-952.
75. 0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 1997, 56:811-821.
76. Nelles E, Butzler C, Jung D, Temme A, Gabriel H-D, Dahl U, Traub O, Stumpel F, Jungermann K, Zielasek J et al.: Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A 1996, 93:9565-9570.
77. Anzini P, Neuberg DH-H, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka K, Suter U, Martini R: Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J Neurosci 1997, 17: 4545-4561.
78. Kunzelmann P, Blumcke I, Traub O, Dermietzel R, Willecke K: Coexpression of connexin45 and -32 in oligodendrocytes of rat brain. J Neurocytol 1997, 26:17-22.
79. Li C, Topak MB, Gerial R, Calpoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J: Myelination in the absence of myelin-associated glycoprotein. Nature 1994, 369:747-750.
80. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave K-A et al.: Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994, 13:229-246.
81. Fruttiger M, Montag D, Schachner M, Martini R: Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 1995, 7:511-515.
82. Carenini S, Montag D, Caremer H, Schachner M, Martini R: Absence of the myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin. Cell Tissue Res 1997, 287:3-9.
83. •].
84. •] show that the lack of galactocerebroside and sulfatide causes subtle anatomical, but profound physiological, demyelination both in the CNS and in the PNS.
85. Ebersole TA, Chen Q, Justice MJ, Artzt K: The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nature Genet 1996, 12:260-265.
86. Hardy RJ, Loushin CL, Friedrich VL Jr, Chen Q, Ebersole TA, Lazzarini RA, Artzt K: Neural cell type-specific expression of OKI proteins is altered in quakingviable mutant mice. J Neurosci 1996, 16:7941-7949.
87. Bolino A, Brancolini V, Bono F, Bruni A, Gambardella A, Romeo G, Quattrone A, Devoto M: Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 1996, 5:1051-1054.
88. Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, King RHH, Ishpekova B, Honeyman K, Calafell F et al Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nature Genet 1996, 14:214-217.
89. Kessali M, Zemmouri R, Guilbot A, Maisonobe T, Brice A, LeGuern E, Grid D: A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease. Neurology 1997, 48:867-873.
90. Bunge MB: Schwann cell regulation on extracellular matrix biosynthesis and assembly. In Peripheral Neuropathy. Edited by Dyck PJ, Thomas PK, Low PA, Poduslo JF. Philadelphia: WB Saunders; 1993:299-316.
91. Chernousov MA, Stahl RC, Carey DJ: Schwann cells secrete a novel collagen-like adhesive protein that binds N-syndecan. J Biol Chem 1996, 271:13844-13853.
92. 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J 1995, 14:4470-4481.
93. Dowling J, Yu QC, Fuchs E: β4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996, 134:559-572.
94. var der Neut R, Krimpenfort P, Calafat J, Niessen CM, Sonnenberg A: Epithelial detachment due to absence of hemidesmosomes in integrin β4 null mice. Nature Genet 1996, 13:366-369.
95. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LVB, Fujita S, Fukutaohi H, Shimizu T, Ruegg MA, Matsumura K: Dystroglycan is a dual receptor for agrin and laminin-2 Schwann cell membrane. J Biol Chem 1996, 271:23418-23423.
96. Matsumura K, Yanada H, Saito F, Sunada Y, Shimizu T: Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromusc Discord 1997, 7:7-12.
97. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP: Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 1994, 269:13729-13732.
98. Xu H, Wu X-R, Wewer UM, Engvall E: Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nature Genet 1994, 8:297-302.
99. +1 → A transversion at the 5′ splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum Mol Genet 1995, 4:2171-2174.
100. Rambukkana A, Salzer JL, Yurcheco PD, Tuoanen EI: Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-α2 chain. Cell 1997, 88:811-821. The Schwann cell receptor for the tuberculosis bacillus is identified.
101. Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson EMJ, Milbrandt J: Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 1996, 384:467-470.
102. Baloh RH, Tansey MG, Goldern JP, Creedon DJ, Heucherroth RO, Keck CL, Zimonjic DB, Popescu NC, Johnson EMJ, Milbrandt J: TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 1997, 18:793-802.
103. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA: Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 1997, 17:1642-1659.
104. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA: Selective activation of NF-kB by nerve growth factor through the neurotrophin receptor p75. Science 1996, 272:542-545.
105. Son YJ, Trachtenberg JT, Thompson WJ: Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Nerurosci 1996, 19:280-285.
106. Takeda Y, Asou H, Murakami Y, Miura M, Kobayashi M, Uyemura K: A nonneuronal isoform of cell adhesion molecule L1: tissue-specific expression and functional analysis. J Neurochem 1996, 66:2338-2349.
107. Araki T, Milbrandt J: Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 1996, 17:353-361.